logo
logo

Iq Capital And Northern Gritstone Lead £3.5M Imperagen Seed Funding Round

Aug 02, 2022almost 3 years ago

Amount Raised

£3.5 Million

Round Type

seed

Biotechnology

Description

IQ Capital and Northern Gritstone have a led a £3.5 million seed funding round in Imperagen, a life sciences company building unique technology to accelerate the development of enzyme biocatalysts.

Company Information

Company

Imperagen

About

Imperagen will use the funding to support the development and validation of its ultra-fast enzyme engineering platform.